Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
HDFCLIFE.NS Stock Summary
Top 10 Correlated ETFs
HDFCLIFE.NS
In the News
HDFCLIFE.NS Financial details
Company Rating
Strong Buy
Market Cap
1012.89B
Income
14.8B
Revenue
668.52B
Book val./share
-
Cash/share
-
Dividend
1.7
Dividend %
0.35%
Employees
24.91K
Optionable
No
Shortable
Yes
Earnings
24 Apr 2023
P/E
70.78
Forward P/E
45.43
PEG
136.3
P/S
1.57
P/B
8.48
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
0.08
-
-
EPS (TTM)
7.09
EPS next Y
10.84
EPS next Q
10.07
EPS this Y
-3.71%
EPS next Y
52.92%
EPS next 5Y
76.16%
EPS last 5Y
3.25%
Revenue last 5Y
15.82%
Revenue Q/Q
-15.16%
EPS Q/Q
-4.52%
-
-
-
-
SMA20
-4.8%
SMA50
-20.15%
SMA100
-11.12%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
11%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
2%
Payout
-
Shs Outstand
2.15B
Shs Float
927.77M
-
-
-
-
Target Price
-
52W Range
457.8-620.6
52W High
-20.56%
52W Low
+7.77%
RSI
49.42
Rel Volume
0.76
Avg Volume
4.48M
Volume
3.42M
Perf Week
5.53%
Perf Month
-5.04%
Perf Quarter
-7.15%
Perf Half Y
-12.01%
-
-
-
-
Beta
0.763157
-
-
Volatility
14.29%, 15.63%
Prev Close
-1.14%
Price
492.5
Change
-1%
HDFCLIFE.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-03-31
Metric | History | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 161.43 | 190.59 | 142.29 | 355.42 | 333.93 | |
Net income per share | 5.52 | 6.34 | 6.43 | 6.74 | 6.57 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 33.45 | 48.76 | 36.37 | 47.74 | 29.14 | |
Cash per share | 15.97 | 15.17 | 8.12 | 17.21 | 15.97 | |
Book value per share | 23.62 | 28.01 | 33.73 | 42.78 | 77.31 | |
Tangible book value per share | 23.36 | 27.79 | 33.56 | 42.57 | 49.22 | |
Share holders equity per share | 23.62 | 28.01 | 33.73 | 42.78 | 77.31 | |
Interest debt per share | 0.05 | 0.07 | 0.08 | 3.2 | 3.43 | |
Market cap | 967.54B | 773.29B | 890.61B | 1406.12B | 1087B | |
Enterprise value | 953.73B | 756.43B | 877.98B | 1399.24B | 1075.44B | |
P/E ratio | 87.39 | 60.51 | 68.64 | 103.32 | 81.92 | |
Price to sales ratio | 2.99 | 2.01 | 3.1 | 1.96 | 1.61 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 14.43 | 7.87 | 12.13 | 14.58 | 18.47 | |
P/B Ratio | 20.43 | 13.7 | 13.08 | 16.27 | 6.96 | |
PTB ratio | 20.43 | 13.7 | 13.08 | 16.27 | 6.96 | |
EV to sales | 2.95 | 1.97 | 3.06 | 1.95 | 1.59 | |
Enterprise value over EBITDA | 80.8 | 56.01 | 63.73 | 96.46 | 74.11 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 14.22 | 7.7 | 11.96 | 14.51 | 18.27 | |
Earnings yield | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0.07 | 0.13 | 0.08 | 0.07 | 0.05 | |
Debt to equity | 22.33 | 22.04 | 18.43 | 19.79 | 13.78 | |
Debt to assets | 0.96 | 0.96 | 0.95 | 0.95 | 0.93 | |
Net debt to EBITDA | -1.17 | -1.25 | -0.92 | -0.47 | -0.8 | |
Current ratio | 0 | 0 | 0 | 0 | 0 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0.01 | 0 | 0 | 0 | |
Payout ratio | 0.3 | 0.31 | 0 | 0 | 0.34 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0.02 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 54.18 | 63.23 | 69.85 | 80.53 | 106.9 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham Net | -511.54 | -602.2 | -613.4 | -829.46 | -1.05K | |
Working capital | 0 | 0 | 0 | 0 | 0 | |
Tangible asset value | 46.83B | 55.99B | 67.71B | 85.98B | 99.41B | |
Net current asset value | 1057.48B | 1243.73B | 1254.17B | 1710.01B | 2151.21B | |
Invested capital | 0 | 0 | 0 | 0.07 | 0.04 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 15.82B | 17.95B | 18.93B | 23.25B | 23.79B | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.23 | 0.23 | 0.19 | 0.16 | 0.08 | |
Capex per share | -0.17 | -0.22 | -0.19 | -0.3 | -0.28 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q3
Metric | History | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 70.81 | 86.5 | 31.74 | 108.72 | 91.72 | |
Net income per share | 1.36 | 2.5 | 1.56 | 1.55 | 1.48 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 15.94 | 0 | 3.09 | 0 | |
Book value per share | 0 | 77.14 | 0 | 58.17 | 0 | |
Tangible book value per share | 0 | 49.11 | 0 | 58.17 | 0 | |
Share holders equity per share | 0 | 77.14 | 0 | 58.17 | 0 | |
Interest debt per share | 0 | 2.96 | 0 | 4.48 | 0 | |
Market cap | 1314.77B | 1089.38B | 1159.2B | 1125.99B | 1208.68B | |
Enterprise value | 0 | 1077.82B | 0 | 1128.92B | 0 | |
P/E ratio | 119.4 | 53.8 | 88.14 | 85.56 | 95.65 | |
Price to sales ratio | 9.17 | 6.22 | 17.33 | 4.88 | 6.17 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 6.98 | 0 | 9.12 | 0 | |
PTB ratio | 0 | 6.98 | 0 | 9.12 | 0 | |
EV to sales | 0 | 6.16 | 0 | 4.89 | 0 | |
Enterprise value over EBITDA | 0 | 227.95 | 0 | 341.54 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 13.78 | 0 | 17.81 | 0 | |
Debt to assets | 0 | 0.93 | 0 | 0.95 | 0 | |
Net debt to EBITDA | 0 | -2.45 | 0 | 0.89 | 0 | |
Current ratio | 0 | 0 | 0 | 0 | 0 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.02 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 65.88 | 0 | 45.04 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | -1.05K | 0 | -1.03K | 0 | |
Working capital | 0 | 0 | 0 | 0 | 0 | |
Tangible asset value | 0 | 99.41B | 0 | 123.47B | 0 | |
Net current asset value | 0 | 2151.21B | 0 | 2198.8B | 0 | |
Invested capital | 0 | 0.04 | 0 | 0.08 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0.03 | 0 | 0.03 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
HDFCLIFE.NS Frequently Asked Questions
What is HDFC Life Insurance Company Limited stock symbol ?
HDFC Life Insurance Company Limited is a IN stock and trading under the symbol HDFCLIFE.NS
What is HDFC Life Insurance Company Limited stock quote today ?
HDFC Life Insurance Company Limited stock price is $492.5 today.
Is HDFC Life Insurance Company Limited stock public?
Yes, HDFC Life Insurance Company Limited is a publicly traded company.